Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025)

Prestige Consumer Healthcare (PBH) posted quarterly Depreciation & Amortization (CF) of $7.6 million for Q4 2025, up 10.54% year-over-year from $6.9 million in Q4 2024, and down 0.93% quarter-over-quarter from $7.7 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $7.6 million for Q4 2025.

  • In Q4 2025, Depreciation & Amortization (CF) rose 10.54% year-over-year to $7.6 million; the TTM figure through Dec 2025 stood at $30.2 million (down 1.92% YoY), while the FY2025 annual figure was $30.2 million, down 1.64% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 stood at $7.6 million, down from $7.7 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $8.5 million in Q1 2022, with the low at $6.9 million in Q4 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $7.8 million (2024), against an average of $7.8 million.
  • The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) rose 12.58% in 2022, then declined 10.18% in 2024.
  • Prestige Consumer Healthcare's Depreciation & Amortization (CF) stood at $8.0 million in 2021, then rose by 0.99% to $8.1 million in 2022, then fell by 5.95% to $7.6 million in 2023, then slipped by 10.18% to $6.9 million in 2024, then climbed by 10.54% to $7.6 million in 2025.
  • Business Quant data shows PBH's Depreciation & Amortization (CF) at $7.6 million in Q4 2025, $7.7 million in Q3 2025, and $7.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.59 Mn
Dec 31, 2025 7.59 Mn
Sep 30, 2025 7.66 Mn
Sep 30, 2025 7.66 Mn
Jun 30, 2025 7.67 Mn
Jun 30, 2025 7.67 Mn
Mar 31, 2025 7.25 Mn
Mar 31, 2025 7.25 Mn
Dec 31, 2024 6.87 Mn
Dec 31, 2024 6.87 Mn
Sep 30, 2024 7.93 Mn
Sep 30, 2024 7.93 Mn
Jun 30, 2024 8.12 Mn
Jun 30, 2024 8.12 Mn
Mar 31, 2024 7.84 Mn
Mar 31, 2024 7.84 Mn
Dec 31, 2023 7.65 Mn
Dec 31, 2023 7.65 Mn
Sep 30, 2023 7.64 Mn
Sep 30, 2023 7.64 Mn